SAN JOSE, Calif. -- Amid losses and order delays, Patrik Lundstrom has been
named acting CEO of Obducat AB (Malmo, Sweden), a supplier of nano-imprint
He assumes the CEO role from Lars Tilly, who resigned ''after a mutual
agreement with the company’s board,'' according to Obducat, the largest
nano-imprint firm. Tilly resigned after only about seven months on the job.
Last year, Tilly assumed the role from Lundstrom, who was the CEO of Obducat
from 2002-to-2009. Lundstrom was re-elected to the board on June 23. But during
the time serving as acting CEO, he will not participate in the board work as a
board of director.
Despite the upturn, the company continues to loss money. It recently reported
its results. Group sales for the quarter amounted to SEK12.848 million ($1.66
million), down from SEK15.427 million ($1.99 million) a year ago.
Loss for Q1 was SEK12.571 million ($1.62 million), compared to a loss of
SEK11.709 million ($1.51 million) a year ago.
As reported, the company is seeing delays for its nano-imprint tool for hard
drives. While nano-imprint has not cracked mainstream production in
semiconductor fabs, as some had hoped at one time, the technology has been
delayed in perhaps its biggest potential market: hard disk drives (HDDs).
''As previously communicated, the technical requirements specification
pertaining to the order for a Sindre HDD system has been changed,'' according to
''Currently there are discussions with the customer on exactly which modules
to supply, in order to in the most flexible way, address the customer’s various
requirements in several application areas, in which bit pattern media (BPM) is
one,'' according to the firm. ''The need for BPM systems for production will
however arise later than DTR on which the HDD industry has been concentrated on
up to now. Therefore the order has been postponed and has for the time being
been removed from the backlog.''
Another nano-imprint supplier is in trouble. As reported, Canon Inc. could
nano-imprint lithography vendor Molecular Imprints Inc. (MII).